John Warren Thomas

Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3.

C. Baum, J. Monahan, M. Abrams, 1995, Proceedings of the National Academy of Sciences of the United States of America.